442 
International  Congresses. 
f Am.  Jour.  Pharm. 
I  September,  1901. 
(5)  The  nomenclature  of  new  remedies  should  be  revised  and  controlled  in 
order  to  avoid  duplicity  or  confusion  of  names  and  errors. 
(6)  The  pharmacopoeias  of  every  country  should  be  provided  with  an  annual 
supplement. 
In  regard  to  the  question  of  nostrums  the  resolution  was  adopted 
that  national  and  local  pharmaceutical  associations  should  co-oper- 
ate with  the  medical  societies,  with  the  object  of  suppressing 
quackery  and  the  use  of  nostrums. 
The  question  on  specialties  was  again  discussed  with  the  customary 
animation  and  dissension.  Finally  the  resolution  prevailed,  "  that 
in  all  countries  laws  should  be  inaugurated  that  all  specialties  should 
publish  on  their  labels  and  in  circulars  the  active  constituents  they 
contain  and  the  average  dose." 
In  conclusion  the  city  of  Paris  was  selected  for  holding  the  next 
Congress  in  1 900. 
NINTH  CONGRESS  IN  PARIS,   1 9OO. 
The  Ninth  International  Pharmaceutical  Congress  was  the  second 
meeting  of  these  conferences  in  Paris  and  at  the  time  of  an  Inter- 
nationa] Exposition,  as  also  of  a  series  of  other  international 
congresses. 
The  programme  sent  out  with  circular  letters  of  invitation  by  the 
French  local  committee  deviated  still  more  from  the  preceding 
ones  and  contained  quite  an  array  of  miscellaneous  questions  grouped 
into  four  sections.  These  were:  (i)  Pharmacy  and  pharmaceutical 
chemistry;  (2)  Materia  medica  and  pharmacognosy;  (3)  Biological 
chemistry,  bacteriology,  hygiene  and  hydrology ;  (4)  Professional 
interests.  A  number  of  communications  and  papers  printed  in  ad- 
vance was  received  and  referred  to  the  respective  sections.  Each 
section  held  separate  sessions. 
The  Congress  convened  in  Paris,  August  2,  1 900.  The  majority  of 
visitors  were  Frenchmen;  no  special  differentiation  was  made  between 
delegates  and  visitors.  Authorized  delegates  from  foreign  pharma- 
ceutical associations  were  present  from  the  following  countries: 
Belgium,  ten;  Germany,  five;  Austria,  two;  Switzerland,  three; 
Roumania,  two  ;  Russia,  one ;  Mexico,  one  ;  Sweden  and  Norway, 
three;  Denmark,  two;  Italy,  three;  Greece,  one;  Spain,  two,  and 
Holland,  two.  Officially  not  represented  were  Great  Britain  and 
the  United  States  of  America.  No  government  was  officially  repre- 
sented. 
